Hee Seung Kim, Jae‐Weon Kim, Hong Wu, Hyun Hoon Chung et al.
AIM: We sought to compare survival and toxicity between paclitaxel/carboplatin (TC) and doxorubicin/cisplatin (AP) for concurrent chemoradiation (CCR) in intermediate- or high-risk endometrioid endometrial cancer. METHODS: The clinical data of 40 patients with intermediate- (FIGO stage IC-IIB, n = 1...